Formulation Of Herbal Drug into Modern Dosage Form
Keywords:
Herbal medicines, phytochemicals, novel drug delivery system, phytosome, bioavailability, therapeutic efficacyAbstract
Herbal medicine, as defined by the World Health Organization (WHO), encompasses the use of herbs, herbal components, preparations, and finished products derived from botanical sources. These remedies are abundant in phytochemicals bioactive compounds such as saponins, flavonoids, glycosides, tannins, alkaloids, and terpenoids - which contribute to their diverse therapeutic effects. Herbal treatments are employed in the management of various health conditions, including gastrointestinal disorders, skin infections, inflammation, migraines, and fatigue. Compared to conventional pharmaceuticals, herbal medicines are generally associated with fewer side effects and greater affordability, enhancing their appeal and accessibility. Recent advancements in pharmaceutical technology have led to the development of novel herbal drug delivery systems such as transfersomes, ethosomes, microspheres, phytosomes, liposomes, polymeric nanoparticles, and nanocapsules that significantly improve the solubility, stability, bioavailability, and targeted delivery of herbal compounds. Among these innovations, phytosome technology stands out as a patented approach that combines herbal extracts with phospholipids to enhance absorption and therapeutic efficacy. These advanced systems not only optimize the pharmacological performance of herbal medicines but also ensure better protection of active ingredients against degradation. The integration of modern delivery technologies with traditional herbal remedies marks a significant evolution in the field, expanding the clinical utility and reinforcing the relevance of herbal medicine in modern healthcare. Ongoing research and development in this area hold promising potential for further innovations and broader therapeutic applications.
Downloads
Metrics
References
Bent S. Herbal medicine in the United States: Review of efficacy, safety, and regulation. J Gen Intern Med 2008; 23(6):854-859.
Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001;135(4):262-268.
Bodeker G, Burford G. Traditional, complementary and alternative medicine: Policy and public health perspectives. Bull World Health Organ 2007;86(1):77-78.
Fasinu PS, Bouic PJ, Rosenkranz B. An overview of the evidence and mechanisms of herb– drug interactions. Front Pharmacol2012; 3: 69. doi: 10.3389/fphar.2012.00069
Bensoussan A, Myers SP, Wu S, O’Connor K. Naturopathic and western herbal medicine practice in Australia: A workforce survey. Complement Ther Med 2004;12(1):17-27.
Van-Wyk BE, deWet H, Van-Heerden FR. An ethnobotanical survey of medicinal plants in the southeastern Karoo, South Africa. S Afr J Bot 2008;74:696-704.
WHO. Traditional Medicine Strategy 2002-2005. Geneva: WHO. p. 2002
Barrett B, Kiefer D, Rabago D. Assessing the risks and benefits of herbal medicine: An overview of scientific evidence. AlternTher Health Med 1999;5: 40-49
Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochiafangchi). N Engl J Med 2000; 342:1686-1692.
Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol2005; 43:901-910.
Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343:1833-1838 .
WHO. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. Vol. 13. Geneva: World Health Organization; 2000.
Shinde VM, Dhalwal K, Potdar M, Mahadik KR. Application of quality control principles to herbal drugs. Int J Phytomedicine 2009; 4-8.
Mosihuzzaman M. Herbal medicine in healthcare—an overview. Nat Prod Commun2012;7(6):807- 812.
Coleman LM, Fowler LL, Williams ME. Use of unproven therapies by people with Alzheimer’s disease. J Am Geriatr Soc 1995;43:747-750.
Ansari FZ, Alam S, Jain P, Akhter S, Ansari MZH. Vitiligo and its herbal treatment. Pharmacol Rev 2008;12:137-113.
Parasuraman U, Thing GS, So DA. Polyherbal formulation: Concept of Ayurveda. Pharmacogn Rev 2014;8(16):73-80.
Spinella M. The importance of pharmacological synergy in psychoactive herbal medicines. Altern Med Rev 2002;7:130-137.
Mahima RA, Deb R, Latheef SK, Abdul Samad H, Tiwari R, Verma AK, et al. Immunomodulatory and therapeutic potentials of herbal, traditional/indigenous and ethnoveterinary medicines. Pak J Biol Sci2012;15:754-774.
Akhtar N, Ali M, Alam MS. Herbal drugs used in dental care. Pharm Rev 2005; 10:61-68.
Seigler DS. Plant Secondary Metabolism. New York: Springer Science Business Media; 1995. doi: 10.1007/978-1-4615-4913-0
Delgoda R, Murray JE. Evolutionary perspectives on the role of plant secondary metabolites. In: Badal S, Delgoda R, editors. Pharmacognosy: Fundamentals, Applications and Strategies. 1st ed. Oxoford, UK: Academic Press; 2017. p. 93-100.
Wink M. Modes of action of herbal medicines and plant secondary metabolites. Medicine. 2015; 2:251- 286.
Harborne JB, Baxter H. Phytochemical Dictionary—A Handbook of Bioactive Compounds from Plants. London, UK: Taylor and Francis; 1993.
Wink M. Functions of plant secondary metabolites and their exploitation in biotechnology. In: Annual Plant Reviews. Vol. 39. London, UK: Wiley-Blackwell; 2010.
Ernst E. The efficacy of herbal medicine—an overview. Fundam Clin Pharmacol 2005; 19(4):405-409.
Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with patient cardiovascular disease. J Am Coll Cardiol 2010; 55(6):515-525.
Calixto J. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol 2000; 33:179-189.
Capasso R, Borrelli F, Aviello G, Mascolo N, Romano B. Phytotherapy and quality of herbal medicines. Fitoterapia 2000; 71(1):58-65.
Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2013; 4:177.
Firenzuoli F, Gori L. Herbal medicine today: Clinical and research issues. eCAM. 2007; 4(S1):37-40.
Tavakoli J, Miar S, Zadehzare MM, Akbari H. Evaluation of effectiveness of herbal medication in cancer care: A review study. Iran J Cancer Prev 2012; 5(3):144-156.
Medina OP, Zhu Y, Kairemo K. Targeted liposomal drug delivery in cancer. Curr Pharm Des 2004; 10:2981-9.
Mandal SC, Mandal M. Current status and future prospects of new drug delivery system. Pharm Times 2010; 42:13-6.
Ajazuddin SS. Applications of novel drug delivery system for herbal formulations. Fitoterapia 2010; 81:680-9.
Goyal A, Kumar S, Nagpal M, Singh I, Arora S. Potential of novel drug delivery systems for herbal drugs. Indian J Pharm Educ Res 2011; 45:225-35.
Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: Food sources andbioavailability. Am J Clin Nutr 2004; 79:727-47.
Chauhan NS, Rajan G, Gopalakrishna B. Phytosomes: A potential phyto-phospholipid carriers for herbal drug delivery. J Pharm Res 2009; 2:1267-70.
Parakh SR, Gothoskar AV. Review of mouth dissolving tablet technologies. Pharmaceutical Technology. Duluth, MN: Advanstar Communications; 2003. p. 47-52.
Blatt Y, Kimmelman E, Cohen D, Rotman A. Microencapsulated and controlled-release herbal formulations. United States Patent; 2002.
Marechal D, Yang Wg, Yuzhang H. Sustained-release microgranules containing Ginkgo biloba extract and the process for manufacturing these. United States Patent; 2009. p.7569236.
Sterer N, Nuas S, Mizrahi B, Goldenberg C, Weiss EI, Domb A, et al. Oral malodor reduction by a palatal mucoadhesive tablet containing herbal formulation. J Dent 2008; 36:535-9.
Sharma A, Sharma US. Liposomes in drug delivery: Progress and limitations. Int J Pharm 1997; 154:123-40.
Zhong H, DengY, Wang X, YangB. Multivesicular liposome formulation for the sustained delivery of breviscapine. Int J Pharm 2005; 301:15-24.
Youfang C, Xianfu L, Hyunjin P, Richard G. Evaluation of artemisnin nanoparticles. NanomedNanotechnol Biol Med 2009; 5:316-22.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.